Access to healthcare
Bringing health to the whole world
We aim to improve access to healthcare and deliver our medicines, services and education to patients around the world by tailoring our programmes to the communities they will serve. In some cases, this means looking at pricing; in others it involves overcoming other barriers to healthcare.
patients accessed hypertension education, screening and treatment through Healthy Heart Africa
Healthy Lung Asia in nine Asian markets
patients benefited from patient access programmes
Our access to healthcare strategy is made up of three elements:
- Expanding disease prevention, awareness and treatment
- Building capacity in areas with limited infrastructure
- Improving affordability and access to underserved patients
Healthcare is a universal right and extending access to healthcare is a global goal to which we can significantly contribute. We work with our industry and partners to remove barriers to access, not build them. Our in-depth understanding of the healthcare systems of emerging countries and healthcare needs of the people who live there has helped us develop our science-based strategy. We develop our programmes to best meet the needs of local communities. In some cases, this means looking at pricing; in others it involves overcoming other barriers to healthcare.
Early access to AstraZeneca investigational medicinal products
We recognise that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enrol in one of our clinical trials. In such circumstances individual patients may be eligible for early access to an AstraZeneca investigational medicinal product.